Report post

How do analysts rate AbbVie (abbv) stock?

Within the last quarter, AbbVie (NYSE: ABBV) has observed the following analyst ratings: According to 8 analyst offering 12-month price targets in the last 3 months, AbbVie has an average price target of $169.38 with a high of $200.00 and a low of $140.00. Below is a summary of how these 8 analysts rated AbbVie over the past 3 months.

How do I see abbv stock tickers?

Log in to see them here or sign up to get started. Visit a quote page and your recently viewed tickers will be displayed here. ABBV | Complete AbbVie Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Is AbbVie (abbv) a good stock to buy?

AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders. Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.

The World's Leading Crypto Trading Platform

Get my welcome gifts